Toremifene vs. Nolva for PCT: Which Is Better?

Post Cycle Therapy or PCT is an essential process for anyone who cycled anabolic steroids and testosterone or prohormones. It’s crucial to have this to help you regulate estrogen levels and get you back to normal after your cycle.

You may need an anti-estrogen support in the form of SERM (Selective Estrogen Receptor Modulator) for proper post cycle therapy in order to avoid unwanted side effects that often ensue after taking steroids and prohormones. Toremifene and Nolva are both effective SERMs for PCT, but which one works best? Let’s find out in this article.

What Is Toremifene?

Torem-Fareston

Toremifene (toremifene citrate), a.k.a. Fareston, is an oral SERM which helps oppose estrogen activity in your system. It is FDA-accepted for use in progressive breast cancer and is being assessed for prostate cancer prevention. It’s a non-steroidal SERM that connects to different estrogen receptors to avoid estrogen hormones from escalating.

Benefits of Toremifene

  • Blocks the effects of excess estrogen
  • Prevents gynecomastia (development of “man boobs”)
  • Increases libido
  • Supports LDL cholesterol and production of HDL cholesterol

Possible Side Effects

All medicines may cause side effects. The severity varies from one individual to another. Taking toremifene for PCT may result to the following common side effects:

  • Vertigo
  • Nausea
  • Loss of appetite
  • Hot flashes
  • Fatigue
  • Joint pain
  • Vaginal discharge

*Stop using toremifene and call your health care provider immediately if you suffer from any of these side effects.

Administration

Toremifene is normally dosed at 30 to 60mg a day.

Safety Tips

  • Consult your doctor to know if you are allergic to toremifene before using this SERM.
  • Make sure your doctor knows your medical history (especially if you’re currently under medication or have serious ailments).

What is Nolva?

Nolva (Tamoxifen Citrate) is a potent and effective SERM with both estrogen agonist and antagonist compounds. As an anti-estrogen, Nolvadex works by attaching to the estrogen receptors in the place of estrogen (which is why breast cancer patients benefit from it). It can also act as estrogen in the liver which is said to promote healthier cholesterol levels. Aside from that, Nolva also has testosterone-boosting properties which is very beneficial for men.

Benefits of Nolva

  • Estrogen blocker
  • Boosts natural testosterone production
  • Lesser risk of developing “gyno”
  • Promotes liver health

Possible Side Effects

  • Headaches
  • Hot flashes
  • Stomach upset
  • Rashes (very rare)

Administration

For PCT use, Nolvadex is usually dosed at 40mg a day for a few weeks, then reduced to 20mg a day for the succeeding weeks and at 10mg a day for the last week. The end of your cycle is determined when you start your Nolva therapy.

Note: As always, seek your doctor’s advice before taking Nolva to ensure it’s safe for use and it won’t affect any medical conditions you may have.

Toremifene vs. Nolva for PCT – Which Should I Use?

In a nutshell, Toremifene and Nolva are both effective SERMS you can use for your post cycle therapy. But, Nolva or Nolvadex is your best and safest choice.

Nolva is readily accessible and more inexpensive so you can get a hold of it anytime, but you will need a prescription. It’s been around longer than toremifene so more studies and feedbacks are available at your disposal. Aside from that, you’ll get to retain more muscle tissue and endurance.

Many users agree that Nolva is more effective for PCT as its anti-estrogen capacity is higher, cholesterol levels are kept at a healthy range and gives your testosterone production a boost especially as your body is in a low testosterone condition after running anabolic steroids and prohormones.

Most importantly, the possible side effects of Nolva are better tolerated by many as compared to toremifene. At most times, side effects are little or none at all.

What's your preferred SERM for PCT? Toremifine or Nolva? Let us know in the comments below.

Tags:

We will be happy to hear your thoughts

Leave a reply